Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
US Army

Generated: May 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 050794

« Back to Dashboard

NDA 050794 describes VIDAZA, which is a drug marketed by Celgene and is included in one NDA. It is available from two suppliers. Additional details are available on the VIDAZA profile page.

The generic ingredient in VIDAZA is azacitidine. There are fourteen drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the azacitidine profile page.
Summary for 050794
Formulation / Manufacturing:see details
Pharmacology for NDA: 050794
Medical Subject Heading (MeSH) Categories for 050794
Suppliers and Packaging for NDA: 050794
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
VIDAZA azacitidine POWDER;IV (INFUSION), SUBCUTANEOUS 050794 NDA AUTHORIZED GENERIC Sandoz Inc 0781-3253 N 0781-3253-94
VIDAZA azacitidine POWDER;IV (INFUSION), SUBCUTANEOUS 050794 NDA AUTHORIZED GENERIC Sandoz Inc 0781-9253 N 0781-9253-94

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:POWDER;IV (INFUSION), SUBCUTANEOUSStrength100MG/VIAL
Approval Date:May 19, 2004TE:APRLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Express Scripts
Johnson and Johnson
Cantor Fitzgerald
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.